14-50118294-A-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_006939.4(SOS2):c.*50T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00418 in 1,469,722 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0033 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 35 hom. )
Consequence
SOS2
NM_006939.4 3_prime_UTR
NM_006939.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.63
Genes affected
SOS2 (HGNC:11188): (SOS Ras/Rho guanine nucleotide exchange factor 2) This gene encodes a regulatory protein that is involved in the positive regulation of ras proteins. Mutations in this gene are associated with Noonan Syndrome-9. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 14-50118294-A-T is Benign according to our data. Variant chr14-50118294-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 1202548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.00428 (5636/1317370) while in subpopulation SAS AF= 0.0169 (1159/68692). AF 95% confidence interval is 0.0161. There are 35 homozygotes in gnomad4_exome. There are 3027 alleles in male gnomad4_exome subpopulation. Median coverage is 19. This position pass quality control queck.
BS2
High AC in GnomAd4 at 502 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00330 AC: 503AN: 152234Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
503
AN:
152234
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00404 AC: 745AN: 184588Hom.: 9 AF XY: 0.00453 AC XY: 450AN XY: 99416
GnomAD3 exomes
AF:
AC:
745
AN:
184588
Hom.:
AF XY:
AC XY:
450
AN XY:
99416
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00428 AC: 5636AN: 1317370Hom.: 35 Cov.: 19 AF XY: 0.00466 AC XY: 3027AN XY: 649098
GnomAD4 exome
AF:
AC:
5636
AN:
1317370
Hom.:
Cov.:
19
AF XY:
AC XY:
3027
AN XY:
649098
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00330 AC: 502AN: 152352Hom.: 3 Cov.: 32 AF XY: 0.00346 AC XY: 258AN XY: 74498
GnomAD4 genome
AF:
AC:
502
AN:
152352
Hom.:
Cov.:
32
AF XY:
AC XY:
258
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
25
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Jul 17, 2018
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at